NPS and Parkinson disease: Further investigations into the abnormal neuropeptide processing that alters the biological profiles of the processed peptides and the effect of L-DOPA on neuropeptide expression and biotransformation are needed to fully understand the role these systems play in PD and LID and their potential as targets for pharmacological intervention.